Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y L Han

Showing results (11-20 of 148) with videos related to

Pageof 15
Sort By:
Zhonghua Xin Xue Guan Bing Za Zhi|January 24, 2019
[Guidance and optimization of percutaneous coronary interventions by intracoronary imaging]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 29, 2018
[Strength our efforts on innovation of medical science and technology to promote the development of cardiovascular cause in China]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 20, 2022
[Mission and responsibility of Chinese cardiovascular physicians in the new era]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|November 15, 2021
[Improve the quality of clinical cardiovascular research in China with the help of artificial intelligence]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|August 18, 2021
[Current status and challenges of interventional therapy for patients with complex high risk coronary artery disease]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 14, 2025
[Seeking truth and be pragmatic, adhering to high-quality development]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|February 3, 2020
[Campaign to manage hypertension and implement Healthy China initiative]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 14, 2024
[Promoting self-reliance and self-strengthening in science and technology, and closely relying on innovation to improve the level of prevention and treatment of cardiovascular diseases in China]Y L Han
Zhonghua Yi Xue Za Zhi|February 13, 2018
[Heparin induced thrombocytopenia should be standaridized for diagnosis and treatment]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|December 20, 2023
[Interpretation of 2023 ESC Guidelines for the management of acute coronary syndromes]Y Li, Y L Han
Pageof 15

Showing results (11-20 of 148) with videos related to

Sort By:
Pageof 15
Zhonghua Xin Xue Guan Bing Za Zhi|January 24, 2019
[Guidance and optimization of percutaneous coronary interventions by intracoronary imaging]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 29, 2018
[Strength our efforts on innovation of medical science and technology to promote the development of cardiovascular cause in China]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 20, 2022
[Mission and responsibility of Chinese cardiovascular physicians in the new era]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|November 15, 2021
[Improve the quality of clinical cardiovascular research in China with the help of artificial intelligence]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|August 18, 2021
[Current status and challenges of interventional therapy for patients with complex high risk coronary artery disease]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 14, 2025
[Seeking truth and be pragmatic, adhering to high-quality development]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|February 3, 2020
[Campaign to manage hypertension and implement Healthy China initiative]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|January 14, 2024
[Promoting self-reliance and self-strengthening in science and technology, and closely relying on innovation to improve the level of prevention and treatment of cardiovascular diseases in China]Y L Han
Zhonghua Yi Xue Za Zhi|February 13, 2018
[Heparin induced thrombocytopenia should be standaridized for diagnosis and treatment]Y L Han
Zhonghua Xin Xue Guan Bing Za Zhi|December 20, 2023
[Interpretation of 2023 ESC Guidelines for the management of acute coronary syndromes]Y Li, Y L Han
Pageof 15